In our experiments, the data on ELOVL2 presented here identify that declined DHA synesis caused by MYCN-mediated ELOVL2 inhibition in neuroblastoma cells contributes to tumor aggressiveness. This evidence concerns the gene MYCN and neuroblastoma.